BioBuzz In Conversation: Kevin Combs, CEO of Molecular Biologicals

By: Steven Surdez, BioBuzz

Kevin Combs, the CEO of Molecular Biologicals out of Charlottesville, Virginia, had a front-row seat to the BioHealth Capital Region’s (BHCR) ascendancy. He is now a vital part of the rise of CVille, the life science cluster within the BHCR that is blossoming in and around the University of Virginia (UVA).

Combs was recruited to join MedImmune by then CEO Dave Mott, becoming the company’s Executive Director of National Vaccine Sales in 2006. He has gone on to have a highly successful career as a life science executive, a serial entrepreneur, and an angel investor. He is a founding member of the Charlottesville Angel Network (CAN). 

Combs currently serves as an Entrepreneur in Residence at UVA and is the CEO of Molecular Biologicals, a leading skin and wound care company that is on a mission to transform wound care. Molecular Biologicals has three approved products—KeragelⓇ, KeragelTⓇ, and KeramatrixⓇ, all of which are based on the company’s Keratin molecule platform.

We recently caught up with Combs to discuss Molecular Biologicals’ history, vision, and future plans, as well as the excitement and enthusiasm about the CVille bio hub percolating in the region.

Click here to read the Q&A on BioBuzz.